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S U M M A R Y
Enhanced surveillance systems have been implemented recently in many countries in order to rapidly
detect and investigate any possible cases of Middle East respiratory syndrome coronavirus (MERS-CoV)
infection among travellers returning from the Middle East, including notably Hajj pilgrims. According to
the available surveillance data, only a few sporadic travel-associated MERS-CoV cases have been
reported outside the Arabian Peninsula so far, mainly in Europe, North Africa, and Asia. These have
resulted in no cases, or limited numbers of secondary cases except in Korea. The vast majority of viral
respiratory infections in pilgrims returning home have been due to seasonal inﬂuenza viruses,
rhinoviruses, and other known coronaviruses distinct from the MERS coronavirus. Inﬂuenza vaccination
should be a priority for all Hajj pilgrims, as recommended by experts.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idThe emergence of severe acute respiratory syndrome coronavi-
rus (SARS-CoV) in 2003 in China,1 the H1N1 inﬂuenza pandemic in
2009,2 and the emergence of Middle East respiratory syndrome
coronavirus (MERS-CoV) in the Kingdom of Saudi Arabia (KSA) in
20123 has aroused widespread fear and concern for their potential
threat to global health security.4,5 Elaborate surveillance and
infection control measures were put in place during the 2009 Hajj.
In the event, it was found that there were more cases of seasonal
inﬂuenza reported than of H1N1.6
One thousand six hundred and twenty-four laboratory-
conﬁrmed cases of MERS-CoV, including 586 related deaths, had
been reported to the World Health Organization as of January 23,
2016 (http://www.who.int/emergencies/mers-cov/en/). Millions
of Muslims, from over 180 countries worldwide, make the annual
pilgrimage to Mecca, Saudi Arabia. Due to the overcrowded
conditions, there is the potential for increased person-to-person* Corresponding author. Tel.: +33 (0)491 96 35 35/36; fax: +33 (0)491 96 89 38.
E-mail address: philippe.gautret@club-internet.fr (P. Gautret).
http://dx.doi.org/10.1016/j.ijid.2016.01.013
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).spread of infectious diseases and a favourable transmission of
respiratory tract infections.6 The occurrence of such events spreads
fear of a massive outbreak among pilgrims that could spread to
their countries of origin.7
This situation has prompted health authorities to establish
enhanced surveillance systems in many countries in order to
rapidly detect and investigate any possible cases of MERS-CoV
infection among travellers returning from the Middle East.
Fortunately, only a few sporadic travel-associated MERS-CoV
cases have been reported outside the Arabian Peninsula, mainly in
Europe, North Africa, and Asia.8,9 These have resulted in no cases,
or some secondary cases, with the notable exception of the
Republic of Korea. In the Republic of Korea, 185 cases were
epidemiologically linked to a single index case who had visited
several countries in the Middle East.10
A large-scale surveillance study has provided interesting
insights into the epidemiology of respiratory tract infections in
travellers returning from the Middle East, including Hajj and
Umrah pilgrims. During September 2012 to October 2013,
77 travellers from the Middle East who met the possible caseciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
P. Gautret et al. / International Journal of Infectious Diseases 47 (2016) 83–8584deﬁnition for MERS were tested in England and two of them tested
positive for MERS-CoV.11 Also, 22 had positive results for
alternative respiratory pathogens, including 10 (13%) cases of
inﬂuenza A or B and four (5%) cases of rhinovirus.9 UK surveillance
data focusing on the period of return of Hajj pilgrims during the
years 2013–2015 (September–October) evidenced inﬂuenza in-
fection in 46% and rhinovirus in 30% of 50 patients suspected of
MERS (https://www.gov.uk/government/publications/health-
protection-report-volume-9-2015/
hpr-volume-9-issue-36-news-9-october). Of the ﬁrst 14 patients
returning from the Middle East who were hospitalized for
respiratory symptoms and screened for MERS-CoV in Marseille,
France in October 2013, nine (64%) were infected with inﬂuenza
and all samples tested negative for MERS-CoV.12 In another small
survey conducted in 2014 in Austria and investigating seven Hajj
pilgrims suspected of MERS, none had MERS-CoV, ﬁve had
inﬂuenza, and two were infected by rhinovirus.13 A survey
conducted among 177 travellers from the Middle East suspected
of MERS on returning to Ontario, Canada in 2012–2014, showed
that none tested positive for MERS-CoV, 41 (23%) were positive for
inﬂuenza, and 35 (20%) for rhinovirus.14 Finally, in a survey
conducted in 2013–2014 in California, USA among 52 patients
suspected of MERS, none was positive for MERS, 17 (33%) were
positive for inﬂuenza, and seven (13%) for rhinovirus.15 Other
pathogens were isolated in smaller proportions, including para-
inﬂuenza viruses, human metapneumovirus, respiratory syncytial
virus, enterovirus, adenovirus, non-MERS coronaviruses, Chlamyd-
ia pneumoniae, and Legionella spp.11–15
Besides surveillance implemented in returned travellers
suspected of MERS, several teams in Egypt, Iran, Saudi Arabia,
France, and Ghana have conducted systematic PCR-based screen-
ing surveys among cohorts of returning Hajj pilgrims indepen-
dently of their clinical status. MERS-CoV carriage was investigated
in four studies and was not detected.12,16–18 Inﬂuenza carriage was
investigated in six studies and its mean prevalence was 3% (range
1–8%);18–23 rhinovirus carriage was investigated in four studies
and its mean prevalence was 13% (range 8–17%).18,21–23 Carriage of
non-MERS coronavirus was investigated in two studies and the
prevalence was found to be 1% and 21%, respectively.21,23 Finally,
the carriage of Streptococcus pneumoniae was investigated in two
studies, which reported prevalences of 20% (nasal carriage) and
62% (throat carriage).22,23 Other viruses were isolated in smaller
proportions, including parainﬂuenza viruses, human metapneu-
movirus, respiratory syncytial virus, enterovirus, and adenovi-
rus.18,21–23 Finally, two PCR-based studies were conducted among
returning Iranian pilgrims suffering from upper respiratory tract
infections and reported a prevalence of inﬂuenza of 10% and 12%,
respectively.24,25
Taken together, these results strongly suggest that Mecca may
act as a global hub for respiratory pathogens through the Muslim
pilgrimage and contribute to their globalization.26
Obviously, the vast majority of viral respiratory infections in
Hajj and Umrah pilgrims returning home are due to seasonal
inﬂuenza viruses, rhinoviruses, and other know coronaviruses
distinct from the MERS coronavirus. Bacteria like S. pneumoniae
may also play a role, as well as Haemophilus inﬂuenzae and
Klebsiella pneumoniae, for which a high rate of acquisition
following participation in the Hajj has been observed in pilgrims
before leaving Saudi Arabia.26 Tuberculosis has also been reported
among patients admitted to hospital during the Hajj;6 however,
given the incubation time of the disease, it is challenging to
identify such cases.
Clinicians should be aware that inﬂuenza is the most commonly
identiﬁed pathogen in returning pilgrims with an acute respiratory
tract infection. However, a microbial cause is not identiﬁed in a
signiﬁcant proportion of patients with a respiratory infection,which makes the overall incidence of inﬂuenza very low. Empirical
antiviral treatment for inﬂuenza on admission when indicated may
be considered pending the results of laboratory investigations,
although oseltamivir resistance among inﬂuenza strains has been
reported. Inﬂuenza vaccination should be a priority for all Hajj
pilgrims, as recommended by experts.27,28 However, since Hajj
dates are now moving to the summer season, the lack of
availability of the inﬂuenza vaccine in many countries during this
period will hamper this strategy. Public health measures intro-
duced by Saudi Arabia in 2015, banning the sacriﬁce of camels for
Hajj and discouraging visits by pilgrims to camel barns during Hajj
pilgrimage activities, are sensible precautionary measures that
should be considered as part of pre-travel advice in the home
countries of pilgrims.
Despite the paucity of actual cases of MERS in travellers
returning from the Middle East and the virtual absence of Hajj-
associated cases in this context, continuous surveillance should be
implemented to ensure the timely detection of possible imported
cases of MERS and their immediate isolation in order to avoid
secondary cases. The recent experience in South Korea, with a
single chain of transmission associated with healthcare facilities
resulting in many cases, is a reminder that enhanced surveillance
at ports of entry is critical. The few pilgrimage-associated cases of
MERS in travellers reported so far were in Umrah pilgrims.7 An
estimated eight million pilgrims perform the Umrah yearly.29 The
number of Umrah pilgrims is particularly high during the month of
Ramadan, and that period could be considered the second mass
gathering in Saudi Arabia, although of a lesser size compared to the
Hajj. Studies on respiratory tract infections during Ramadan are
scarce; thus continued surveillance of respiratory infections and of
the spectrum of associated pathogens among pilgrims returning
from the Umrah during Ramadan and from the subsequent Hajj is
of critical importance.
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